San Francisco, California – Yavne, Israel – Genopore, the next-generation proteomics company developing the first semiconductor based optical nanopore technology platform with AI/ML analysis for direct single protein molecule identification and digital quantification, today announced the appointment of life science leader Rey Mali as its new Chief Executive Officer, with immediate effect. Rey Mali brings more […]
SAN JOSE, Calif. — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. (“Takara Bio”), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 after more than two decades with the company. Andrew Farmer, D.Phil., who has served as Chief Scientific […]
Uppsala, Sweden – Navinci Diagnostics AB (”Navinci”) today announces that the Company has initiated a pilot project together with Lumito AB (publ) (“Lumito”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis platform with Navinci’s in situ Proximity Ligation Technology (isPLA). By […]
Uppsala, Sweden — Navinci Diagnostics AB (”Navinci”) today announces that the Company has initiated a pilot project together with Lumito AB (publ) (“Lumito”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis platform with Navinci’s in situ Proximity Ligation Technology (isPLA). By […]
New leaders bring extensive leadership experience across life sciences, diagnostics, and medical technology SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Mike Sullivan as Chief Commercial Officer, effective July 20, 2026, and Julie Coletti as Chief Legal Officer, effective August 3, 2026. The appointments add experienced leaders to Illumina’s Executive Leadership […]
Advancing Scalable Reproducible Cell Therapy and Advanced Cell Culture Workflows New heat-stable and hyperactive proteins across the fibroblast growth factor and interleukin cytokine families expand the R&D Systems™ AI-Engineered Designer Protein portfolio AI-guided protein design supports improved consistency, performance and scalability in complex cell culture workflows Engineered signaling proteins help address key challenges in scaling […]
DURHAM, NC, USA — Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, and EpiCypher®, the leading provider of ChIC/CUT&RUN technology, today announced a partnership to help researchers generate high-confidence epigenomic insights faster. By combining EpiCypher’s CUTANA™ ChIC/CUT&RUN platform with Abcam’s expertise in antibody development and characterization, the collaboration aims to co-develop and validate reagents that […]
Pleasanton, CA — Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job, launched Lil’ Tuna today, the first fully automated, plate-based, benchtop buffer exchange system. Unchained’s been automating buffer exchange forever — with Big Tuna for plate exchanges and Unagi for walk-up processing of individual samples. […]
Seer is Delivering Clear Progress Against its Strategic Plan and Maintaining Focus on Cost Discipline, Governance Rigor and Product Innovation Highly Qualified, Independent and Accountable Board Has Taken Decisive Action to Advance Stockholders’ Best Interests Board Urges Stockholders to Vote “FOR” ONLY Seer’s Director Nominees on the BLUE Proxy Card REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: […]
Recently, ACROBiosystems has officially received the “Material Suitability Confirmation for Regenerative Medicine Products” (Certificate No.: 薬機審長発第47号) from the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan for its GMP-grade Human IL-15 protein. This recognition further validates ACROBiosystems’ quality system and serves as an authoritative endorsement of its compliance capabilities and expertise in the core raw […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
